Showing results for Alzheimer's disease

IU School of Medicine names Apostolova associate dean for Alzheimer’s disease research

Liana G. Apostolova, MS, MD, FAAN, has been named associate dean for Alzheimer’s disease research at Indiana University School of Medicine. The role is a newly established leadership position on the research cabinet of Tatiana Foroud, PhD, executive associate dean for research affairs at the school.

IU School of Medicine | May 11, 2023

IU neuroscientists lead new study laying groundwork for Alzheimer’s disease precision medicine

Researchers at Indiana University School of Medicine are co-leading a 5-year, $41 million study to better understand the biological pathways underlying Alzheimer’s disease and ultimately create more personalized patient care.

IU School of Medicine | Mar 28, 2023

Alzheimer’s disease researchers study gene associated with the brain’s immune cells

Indiana University School of Medicine researchers are studying how the reduction of a gene variant found in the brain’s immune cells could diminish the risk of late-onset Alzheimer’s disease.

IU School of Medicine | Jan 05, 2023

Neuroscience researcher Debomoy Lahiri, PhD, elected to National Academy of Inventors

Indiana University School of Medicine distinguished professor Debomoy Lahiri, PhD, has been named a 2022 fellow of the National Academy of Inventors – the highest professional distinction awarded to academic inventors.

IU School of Medicine | Dec 16, 2022

New $3.5 million grant to aid in identification of new neurodegenerative diseases

Researchers from Indiana University School of Medicine and the University of Toronto have been awarded a five-year, $3.5 million grant from the National Institute on Aging (NIA) to identify new neurodegenerative disorders that are often misdiagnosed as other conditions.

IU School of Medicine | Dec 08, 2022

IU researchers study relationship between epilepsy drug and Alzheimer’s disease

Researchers from an Indiana University School of Medicine-led consortium of Alzheimer’s disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential therapeutic for Alzheimer’s disease.

IU School of Medicine | Nov 30, 2022

Pablo Martinez, PhD and Cristian Lasagna-Reeves, PhD

IU researchers identify protein that contributes to tau neurotoxicity in Alzheimer’s disease

Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found in neurons that appear abnormal in the brains of Alzheimer’s disease patients.

IU researchers investigate brain’s immune cell response in Alzheimer’s disease

Indiana University School of Medicine researchers are investigating how the deficiency of a gene in immune cells can shape the progression of Alzheimer’s disease.

IU Alzheimer’s study awarded nearly $50 million by NIH to continue groundbreaking research

The second largest federally funded research program at Indiana University School of Medicine will receive $48.8 million over the next five years, fueling the work of researchers as they seek to discover treatments for Alzheimer’s disease.

IU School of Medicine | Sep 29, 2022

Alzheimer’s researchers study drug efficacy in early stages of disease

Most drugs developed to treat Alzheimer’s disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.

IU School of Medicine | Jul 25, 2022